ANEW Medical Advances Neuro and Weight Loss Therapies
Category: Stocks Total Views: 50By : Ryan Hughes Updated: 08-11-2024
Introduction to ANEW Medical, Inc.
Pioneering biopharmaceutical company ANEW Medical, Inc. (NASDAQ: WENA) is committed to create creative, disease-modifying treatments aiming at the brain and central nervous system (CNS). Among the most difficult neurodegenerative diseases the company targets are Alzheimer's, Parkinson's, amyotrophic lateral sclerosis (ALS), and several types of cancer. By means of innovative research and development, ANEW Medical seeks to fulfill major un... Read More
Webuy Global Lands $2M to Drive Expansion in Southeast Asia
Category: Stocks Total Views: 5By : Henry Turner Updated: 08-10-2024
Senior Convertible Debt Agreement with Accredited Institutional Investor
Webuy Global Ltd. (Nasdaq: WBUY) announced a new senior convertible debt agreement with an initial principal amount of $2 million. The company could be able to get an extra $4 million, subject to mutual agreement with the accredited institutional investor engaged. Set at $0.213 per share, which is 150% of the company's Class A ordinary shares' volume-weighted average price (VWAP) on the trading day be... Read More
Economic Boost and Clean Energy: Gevo’s NZ1 Explained
Category: Stocks Total Views: 11By : Dominic Sanders Updated: 08-10-2024
The Strategic Importance of Gevo's Net-Zero 1 Facility
Based on a key analysis by Charles River Associates (CRA), Gevo, Inc. (NASDAQ: GEVO) has revealed the major environmental and financial advantages linked with the manufacturing of sustainable aviation fuel (SAF). With a thorough examination of the possible effects, this paper centers on Gevo's intended Net-Zero 1 (NZ1) alcohol-to---jet (ATJ) SAF facility in South Dakota. CRA's research shows that every dollar spent... Read More
Needle-Free Neffy Spray: A Breakthrough for Anaphylaxis
Category: Stocks Total Views: 28By : Caleb Price Updated: 08-10-2024
FDA Approves Neffy® Nasal Spray for Severe Allergic Reactions
Leading biopharmaceutical developer of treatments for severe allergic reactions, ARS Pharmaceuticals, Inc. (Nasdaq: SPRY) reached a major turning point with FDA approval of neffy® (epinephrine nasal spray) 2 mg. Now approved for use in adults and children weighing 66 pounds or more experiencing Type I Allergic Reactions, including potentially fatal anaphylaxis, this novel treatment is First needle-free epinephri... Read More
OneMedNet Leads in AI-Powered Real World Data Solutions
Category: Stocks Total Views: 71By : Riley Hayes Updated: 08-10-2024
Introduction to OneMedNet Corporation
Leading curating and managing of regulatory-grade Real World Data (RWD) is OneMedNet Corporation (Nasdaq: ONMD). By including its own artificial intelligence technology into its data curating procedures, the company has lately made a big advance. Along with simplifying the de-identification of patient data, this invention significantly cut running expenses. OneMedNet has improved its capacity to process enormous volumes of clinical data by usi... Read More